Document Type
Table
Review Code
EOC220302 RR Table
Question Submitted
March 1, 2022
Date Completed
March 10, 2022
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC220302 RR Table
Question Submitted
March 1, 2022
Date Completed
March 10, 2022
Status
3. Completed
Research Team
EOC
Category
Clinical Management
Infection Prevention and Control
Subject
Infection Prevention and Control
Immunity
Risk
Vaccines
Population
All
Clinical Setting
Community
Primary care
Public Health
Priority Level
Level 2 One week (7 days)
Cite As
Badea, A; Groot, G; Reeder, B; Miller, L. What is the safety/efficacy of the Novavax COVID-19 vaccine? 2022 Mar 10. Document no.: EOC220302 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. 8 p. (CEST Table)
Related Documents
Documents

EOC220302 RR Table

Download File
Less detail